2023-01-012023-12-312023-12-31false13683163EVAM ANALYTICS LIMITED2024-09-0262012iso4217:GBPxbrli:pure136831632023-01-01136831632023-12-31136831632023-01-012023-12-31136831632021-10-15136831632022-12-31136831632021-10-152022-12-3113683163bus:SmallEntities2023-01-012023-12-3113683163bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3113683163bus:FullAccounts2023-01-012023-12-3113683163bus:PrivateLimitedCompanyLtd2023-01-012023-12-3113683163core:WithinOneYear2023-12-3113683163core:AfterOneYear2023-12-3113683163core:WithinOneYear2022-12-3113683163core:AfterOneYear2022-12-3113683163core:ShareCapital2023-12-3113683163core:SharePremium2023-12-3113683163core:RevaluationReserve2023-12-3113683163core:OtherReservesSubtotal2023-12-3113683163core:RetainedEarningsAccumulatedLosses2023-12-3113683163core:ShareCapital2022-12-3113683163core:SharePremium2022-12-3113683163core:RevaluationReserve2022-12-3113683163core:OtherReservesSubtotal2022-12-3113683163core:RetainedEarningsAccumulatedLosses2022-12-3113683163core:LandBuildings2023-12-3113683163core:PlantMachinery2023-12-3113683163core:Vehicles2023-12-3113683163core:FurnitureFittings2023-12-3113683163core:OfficeEquipment2023-12-3113683163core:NetGoodwill2023-12-3113683163core:IntangibleAssetsOtherThanGoodwill2023-12-3113683163core:ListedExchangeTraded2023-12-3113683163core:UnlistedNon-exchangeTraded2023-12-3113683163core:LandBuildings2022-12-3113683163core:PlantMachinery2022-12-3113683163core:Vehicles2022-12-3113683163core:FurnitureFittings2022-12-3113683163core:OfficeEquipment2022-12-3113683163core:NetGoodwill2022-12-3113683163core:IntangibleAssetsOtherThanGoodwill2022-12-3113683163core:ListedExchangeTraded2022-12-3113683163core:UnlistedNon-exchangeTraded2022-12-3113683163core:LandBuildings2023-01-012023-12-3113683163core:PlantMachinery2023-01-012023-12-3113683163core:Vehicles2023-01-012023-12-3113683163core:FurnitureFittings2023-01-012023-12-3113683163core:OfficeEquipment2023-01-012023-12-3113683163core:NetGoodwill2023-01-012023-12-3113683163core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3113683163core:ListedExchangeTraded2023-01-012023-12-3113683163core:UnlistedNon-exchangeTraded2023-01-012023-12-3113683163core:MoreThanFiveYears2023-01-012023-12-3113683163core:Non-currentFinancialInstruments2023-12-3113683163core:Non-currentFinancialInstruments2022-12-3113683163dpl:CostSales2023-01-012023-12-3113683163dpl:DistributionCosts2023-01-012023-12-3113683163core:LandBuildings2023-01-012023-12-3113683163core:PlantMachinery2023-01-012023-12-3113683163core:Vehicles2023-01-012023-12-3113683163core:FurnitureFittings2023-01-012023-12-3113683163core:OfficeEquipment2023-01-012023-12-3113683163dpl:AdministrativeExpenses2023-01-012023-12-3113683163core:NetGoodwill2023-01-012023-12-3113683163core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3113683163dpl:GroupUndertakings2023-01-012023-12-3113683163dpl:ParticipatingInterests2023-01-012023-12-3113683163dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3113683163core:ListedExchangeTraded2023-01-012023-12-3113683163dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3113683163core:UnlistedNon-exchangeTraded2023-01-012023-12-3113683163dpl:CostSales2021-10-152022-12-3113683163dpl:DistributionCosts2021-10-152022-12-3113683163core:LandBuildings2021-10-152022-12-3113683163core:PlantMachinery2021-10-152022-12-3113683163core:Vehicles2021-10-152022-12-3113683163core:FurnitureFittings2021-10-152022-12-3113683163core:OfficeEquipment2021-10-152022-12-3113683163dpl:AdministrativeExpenses2021-10-152022-12-3113683163core:NetGoodwill2021-10-152022-12-3113683163core:IntangibleAssetsOtherThanGoodwill2021-10-152022-12-3113683163dpl:GroupUndertakings2021-10-152022-12-3113683163dpl:ParticipatingInterests2021-10-152022-12-3113683163dpl:GroupUndertakingscore:ListedExchangeTraded2021-10-152022-12-3113683163core:ListedExchangeTraded2021-10-152022-12-3113683163dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-10-152022-12-3113683163core:UnlistedNon-exchangeTraded2021-10-152022-12-3113683163core:NetGoodwill2023-12-3113683163core:IntangibleAssetsOtherThanGoodwill2023-12-3113683163core:LandBuildings2023-12-3113683163core:PlantMachinery2023-12-3113683163core:Vehicles2023-12-3113683163core:FurnitureFittings2023-12-3113683163core:OfficeEquipment2023-12-3113683163core:AfterOneYear2023-12-3113683163core:WithinOneYear2023-12-3113683163core:ListedExchangeTraded2023-12-3113683163core:UnlistedNon-exchangeTraded2023-12-3113683163core:ShareCapital2023-12-3113683163core:SharePremium2023-12-3113683163core:RevaluationReserve2023-12-3113683163core:OtherReservesSubtotal2023-12-3113683163core:RetainedEarningsAccumulatedLosses2023-12-3113683163core:NetGoodwill2022-12-3113683163core:IntangibleAssetsOtherThanGoodwill2022-12-3113683163core:LandBuildings2022-12-3113683163core:PlantMachinery2022-12-3113683163core:Vehicles2022-12-3113683163core:FurnitureFittings2022-12-3113683163core:OfficeEquipment2022-12-3113683163core:AfterOneYear2022-12-3113683163core:WithinOneYear2022-12-3113683163core:ListedExchangeTraded2022-12-3113683163core:UnlistedNon-exchangeTraded2022-12-3113683163core:ShareCapital2022-12-3113683163core:SharePremium2022-12-3113683163core:RevaluationReserve2022-12-3113683163core:OtherReservesSubtotal2022-12-3113683163core:RetainedEarningsAccumulatedLosses2022-12-3113683163core:NetGoodwill2021-10-1513683163core:IntangibleAssetsOtherThanGoodwill2021-10-1513683163core:LandBuildings2021-10-1513683163core:PlantMachinery2021-10-1513683163core:Vehicles2021-10-1513683163core:FurnitureFittings2021-10-1513683163core:OfficeEquipment2021-10-1513683163core:AfterOneYear2021-10-1513683163core:WithinOneYear2021-10-1513683163core:ListedExchangeTraded2021-10-1513683163core:UnlistedNon-exchangeTraded2021-10-1513683163core:ShareCapital2021-10-1513683163core:SharePremium2021-10-1513683163core:RevaluationReserve2021-10-1513683163core:OtherReservesSubtotal2021-10-1513683163core:RetainedEarningsAccumulatedLosses2021-10-1513683163core:AfterOneYear2023-01-012023-12-3113683163core:WithinOneYear2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:CostValuation2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3113683163core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3113683163core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3113683163core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3113683163core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3113683163core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3113683163bus:Director12023-01-012023-12-3113683163bus:Director22023-01-012023-12-3113683163bus:Director32023-01-012023-12-31

EVAM ANALYTICS LIMITED

Registered Number
13683163
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2023

EVAM ANALYTICS LIMITED
Company Information
for the year from 1 January 2023 to 31 December 2023

Directors

ALHAS, Fikri Can
NELSON, Giles, Dr
STALKER, Norman Anthony

Registered Address

124 City Road
London
EC1V 2NX

Registered Number

13683163 (England and Wales)
EVAM ANALYTICS LIMITED
Balance Sheet as at
31 December 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Investments37,692,6875,324,497
7,692,6875,324,497
Current assets
Debtors489,793-
Cash at bank and on hand15,1931,741,315
104,9861,741,315
Creditors amounts falling due within one year5(1,960)(13,825)
Net current assets (liabilities)103,0261,727,490
Total assets less current liabilities7,795,7137,051,987
Net assets7,795,7137,051,987
Capital and reserves
Called up share capital12,75010,000
Share premium7,063,3915,341,291
Other reserves802,7591,745,868
Profit and loss account(83,187)(45,172)
Shareholders' funds7,795,7137,051,987
The financial statements were approved and authorised for issue by the Board of Directors on 2 September 2024, and are signed on its behalf by:
STALKER, Norman Anthony
Director
Registered Company No. 13683163
EVAM ANALYTICS LIMITED
Notes to the Financial Statements
for the year ended 31 December 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20232022
Average number of employees during the year11
3.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 January 235,324,4975,324,497
Additions2,368,1902,368,190
At 31 December 237,692,6877,692,687
Net book value
At 31 December 237,692,6877,692,687
At 31 December 225,324,4975,324,497

Notes

1Investments in group undertakings and participating interests
4.Debtors: amounts due within one year

2023

2022

££
Amounts owed by associates and joint ventures / participating interests81,948-
Other debtors7,845-
Total89,793-
5.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables1,96010,000
Taxation and social security-3,055
Other creditors-770
Total1,96013,825